Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Harvard Business School
Baxter
Colorcon
Dow

Last Updated: June 25, 2022

Heritage Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HERITAGE PHARMS INC, and what generic and branded alternatives to HERITAGE PHARMS INC drugs are available?

HERITAGE PHARMS INC has thirteen approved drugs.



Summary for Heritage Pharms Inc
US Patents:0
Tradenames:13
Ingredients:12
NDAs:13

Drugs and US Patents for Heritage Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 040858-003 Feb 26, 2010 DISCN No No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc LIMBITROL amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-001 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc CALCIUM ACETATE calcium acetate TABLET;ORAL 202885-001 Jan 22, 2015 AB RX No No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc ALPRAZOLAM alprazolam TABLET, EXTENDED RELEASE;ORAL 078489-003 Oct 17, 2008 DISCN No No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc ALPRAZOLAM alprazolam TABLET, EXTENDED RELEASE;ORAL 078489-001 Oct 17, 2008 DISCN No No See Plans and Pricing See Plans and Pricing
Heritage Pharms Inc LIMBITROL DS amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-002 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Heritage Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Heritage Pharms Inc LIMBITROL amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-001 Approved Prior to Jan 1, 1982 4,316,897 See Plans and Pricing
Heritage Pharms Inc LIMBITROL DS amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-002 Approved Prior to Jan 1, 1982 4,316,897 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Johnson and Johnson
Mallinckrodt
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.